Youngen Pipeline

January 12, 2026 · San Francisco, USA , the 44th Annual J.P. Morgan Healthcare Conference (hereinafter referred to as the "JPM Conference") kicked off grandly. Beijing Youngen Biotechnology...

From January 12 to 15, 2026, the 44th J.P. Morgan Healthcare Conference, the world's largest and most informative cooperation, exchange, and investment conference in the healthcare industry, will ...

Small nucleic acid drugs, especially small interfering RNA (siRNA) and antisense oligonucleotides (ASO), have shown great potential in gene silencing and the treatment of various diseases. By precisel...

Small nucleic acid drugs, especially siRNA and ASO, have become important therapeutic tools in the biomedical field. These drugs, through precise regulation of gene expression, have opened new pathway...

RNA interference (RNAi) is a natural gene-silencing mechanism triggered by double-stranded RNA (dsRNA) that can specifically inhibit the expression of target genes. Since Fire and Mello first discover...

Small nucleic acid drugs, as an emerging therapy, show many advantages compared to existing small molecule drugs and antibody drugs. Their development process is shorter, the therapeutic effects are s...